Tumour-associated expression of CA IX (carbonic anhydrase IX) is to a major extent regulated by HIF-1 (hypoxia-inducible factor-1) which is important for transcriptional activation and consists of the oxygen-regulated subunit HIF-1α and the partner factor ARNT [AhR (aryl hydrocarbon receptor) nuclear translocator]. We have previously observed that HIF-1α competes with the AhR for interaction with ARNT under conditions when both conditionally regulated factors are activated. We have therefore investigated whether TCDD (2,3,7,8-tetrachlorodibenzop-dioxin)-induced activation of the AhR pathway might interfere with CA IX expression. The results from the present study suggest that TCDD treatment reduces hypoxic induction of both CA IX mRNA and protein expression. Moreover, the transcriptional activity of the CA9 promoter was significantly reduced by expression of CAAhR (constitutively active AhR), which activates transcription in a ligand-independent manner. Finally, we found that ARNT is critical for both hypoxic induction and the TCDDmediated inhibition of CA9 expression.
INTRODUCTION
CA IX (carbonic anhydrase IX) belongs to the family of Zn 2+ binding metalloenzymes (carbonic anhydrases) that catalyse the reversible conversion of carbon dioxide to bicarbonate and proton and are thus involved in gas exchange, ion transport and the acid-base balance across cell membranes and between different intracellular compartments [1] . Fifteen human carbonic anhydrases identified to date participate in a variety of physiological processes such as respiration, bone resorption, gluconeogenesis, renal acidification, formation of cerebrospinal fluid and gastric acid [2] [3] [4] .
Besides physiological expression, several carbonic anhydrase isoforms have been described to be deregulated in various types of malignances [5] [6] [7] [8] . So far, the most studied carbonic anhydrase related to oncogenesis is CA IX [9, 10] . The strong association of CA IX expression with tumour development is mainly related to diminished oxygen supply, hypoxia [11, 12] . In general, the primary cellular response to hypoxia is the stabilization of the HIF-1 (hypoxia-inducible factor-1) transcriptional complex composed of a constitutively expressed ARNT [AhR (aryl hydrocarbon receptor) nuclear translocator, also known as HIF-1β] and the rate-limiting subunit HIF-1α, which is regulated by oxygen availability [13] . The resulting HIF-1 complex activates transcription of a variety of genes, the promoters of which contain HREs (hypoxia response elements; 5 -RCGTG-3 ). CA9 (the CA IX gene) belongs to a group of genes with a very strong hypoxia response, mainly due to the unique localization of its HRE just − 3/− 10 nucleotides from the transcription start site [12] . Moreover, an efficient hypoxia response is achieved through HIF-1 and SP1 co-operation on the CA9 promoter [11] . The basal promoter of the CA9 gene is localized within a sequence of approx. 200 nucleotides upstream of the transcription start site.
In addition to hypoxia, expression of CA IX is also enhanced by high cell density in cell culture models [14] and modulated by the PI3K (phosphoinositide 3-kinase) and MAPK (mitogen-activated protein kinase) pathways [14] [15] [16] . Moreover, extracellular acidosis, which is characteristic for most solid tumours, increases CA IX at both protein and mRNA levels in certain cell types [17] . However, it is clear that CA IX expression could be modulated by an interplay between several stimuli and pathways, with HIF-1 and SP1 representing the crucial targets of these pathways.
During the past decades, increasing attention has started to be paid to the role of various environmental contaminants in the process of cancer development. Direct cellular response to the action of these toxic compounds is the induction of xenobioticmetabolizing enzymes among which cytochrome P450 (CYP1A1) is best characterized (reviewed in [18] ). The environmental toxin TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) induces a broad spectrum of biochemical and toxic effects such as teratogenesis, immunosupression and tumour development [19] . Its effects are at the molecular level, primarily mediated through activation of the AhR [20] . Under conditions when physiological ligand or TCDD are absent, AhR is present in the cytoplasm and forms a complex stably associated with Hsp90 (heat-shock protein 90) and additional co-chaperone proteins [21] . After ligand binding, the activated AhR translocates into the nucleus [22] , where it dimerizes with ARNT, allowing both proteins to recognise the asymmetrical E-box motif known as XRE (xenobiotic response element, 5 -GCGTG-3 ), which is involved in the regulation of dioxin-responsive genes [23] .
AhR, HIF-1α and ARNT belong to a group of structurallyrelated transcription factors known as the bHLH (basic helixloop-helix)-PAS (Per/ARNT/Sim) family of proteins [24] . The main characteristic of PAS proteins is their ability to form various homo-and hetero-dimeric complexes, which regulate expression of target genes. The ability of ARNT to act as a heterodimeric partner for both HIF-1α and AhR raises the possibility of crosstalk between the hypoxia and dioxin signalling cascades. The studies published to date seem to indicate that the degree of interaction among ARNT-dependent pathways might be cell-, tissue-or species-specific [25, 26] and may depend on cellular abundance of ARNT [27] . Consequently, a possible competition for ARNT may lead to regulation of target gene expression in a positive or negative manner. Therefore, the aim of our study was to elucidate whether dioxin activation of the AhR pathway could interfere with the expression of the hypoxia marker CA IX.
MATERIALS AND METHODS

Cell culture and dioxin treatment
Mouse hepatoma cell lines, wild-type Hepa-1c1c7 and the ARNTdeficient subline Hepa-1c4, as well as HeLa cells derived from human cervical carcinoma, were cultured in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FCS (fetal calf serum; BioWhittaker, Verviers, Belgium) and 40 μg/ml gentamicin (Lek, Ljubljana, Slovenia) in a humidified atmosphere with 5 % CO 2 at 37
• C. Hypoxic treatments were performed in an anaerobic workstation (Ruskin Technologies, Bridgend, U.K.) in 2 % O 2 , 5% CO 2 , 10% H 2 and 83 % N 2 at 37
• C. TCDD was diluted to working concentrations of 1 nM or 10 nM. The final concentration of DMSO was less than 0.1 % including controls. Cells were pre-treated with TCDD or DMSO for 1 h prior to being placed into hypoxia (2 % O 2 ) for an additional 24 h. Parallel control dishes were pre-treated and maintained in normoxia (21 % O 2 ) for the same time period.
Antibodies and plasmids
Mouse monoclonal antibody M75, specific for the human MN/CA IX protein, was characterized previously in [28] . Antiactin goat polyclonal antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Secondary anti-mouse peroxidase-conjugated antibody was from Sevapharma (Prague, Czech Republic) and anti-goat peroxidase-conjugated antibody was from Dako (Glostrup, Denmark). For ChIP (chromatin immunoprecipitation), rabbit polyclonal antibody against ARNT was used as described in [29] . Anti-human IgG antibodies (rabbit polyclonal; Abcam, Cambridge, U.K.) were used as a negative control and for chromatin preclearing.
Human promoter constructs were generated by an insertion of PCR-amplified − 50/+ 37 and − 174/+ 37 CA9 genomic fragments upstream of the firefly luciferase gene in pGL3-Basic luciferase reporter vector (Promega, Madison, WI, U.S.A.) [16] . pRL-TK Renilla vector (Promega) served as a transfection efficiency control. Plasmids containing full-length ARNT (pARNT/GEM7), XRE-driven reporter gene construct pTX.DIR, and dioxin receptor deletion mutant lacking the minimal PAS B motif (DR PASB) that functions as a CAAhR (constitutively active AhR) have been described previously in [30] [31] [32] . HIF-1α cDNA in pcDNA1 expression plasmid [33] was provided by Professor Patrick Maxwell (Division of Medicine, Imperial College, London, U.K.). Plasmid containing SP1 cDNA was generated by Dr Robert Tjian and purchased from Addgene (plasmid number 12097, Cambridge, MA, U.S.A.). CBP/p300 expression plasmid was provided by Dr Jiri Vachtenheim (Third Faculty of Medicine, Prague, Czech Republic).
Transfection and luciferase assay
Cells were plated into 35-mm-diameter Petri dishes to reach ∼ 70 % density on the following day. Transient transfection was performed with 1 μg of promoter-containing luciferase construct and 50 ng of pRL-TK plasmid DNA using GenePorterII reagent (Genlantis, San Diego, CA, U.S.A.) according to the manufacturer's recommendations. To analyse the effect of CAAhR either with or without transcription factors (ARNT, HIF-1α, SP1 or p300), the plasmids containing corresponding cDNAs were co-transfected. Cells transfected with control empty vectors (pCMV) served as negative controls. The day after transfection, cells were trypsinized and plated in triplicate into 24-well plates. Cells were allowed to attach for 24 h, and then they were either transferred to hypoxia or maintained in normoxia for an additional 24 h. Reporter gene expression was assessed 72 h after transfection using Dual-Luciferase Reporter Assay System (Promega), and luciferase activity was normalized against Renilla activity.
Western blotting
HeLa cells were plated in 35-mm-diameter Petri dishes to reach ∼ 90 % density on the following day. Pre-treatment with TCDD or DMSO was performed 1 h before the induction of hypoxia in the anaerobic workstation. Parallel control dishes were pre-treated and maintained in normoxia for the same time period. 24 h later, the cells were lysed in ice-cold RIPA buffer (1 % Triton X-100 and 1 % deoxycholate in PBS) containing protease inhibitors (Roche Applied Science, Mannheim, Germany) for 30 min on ice. Cell lysates were scraped off and centrifuged at 10 000 g for 10 min at 4
• C. Protein concentration was determined using the BCA (bicinchoninic acid) protein assay reagent (Pierce, Rockford, IL, U.S.A.).
Total protein extracts (50 μg/lane) were separated on SDS/10 % PAGE and transferred on to PVDF membranes (Immobilon TM -P, Millipore, Billerica, MA, U.S.A.). For CA IX detection, the membrane was incubated with M75 primary antibody diluted 1:2 in blocking buffer for 1 h. Secondary antimouse peroxidase-conjugated antibody (Sevapharma) was diluted 1:7500 in blocking buffer. For loading control, the membrane was probed with anti-actin antibody (Santa Cruz) and the polyclonal rabbit anti-goat IgG-HRP (horseradish peroxidase; Dako). The membrane was developed by ECL ® (enhanced chemiluminescence) using an ECL ® kit (Amersham Pharmacia Biotech, Buckinghamshire, UK).
The intensity of bands corresponding to individual proteins was evaluated with ImageJ 1.38x software (Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, MD, U.S.A., http://rsb.info.nih.gov/ij/, 1997-2007). ImageJ can create density histograms and calculate area and pixel value statistics of userdefined selections. The amount of proteins was expressed as the ratio of the intensity of each band to the intensity of the related actin internal standard.
Reverse transcription-PCR
Total RNA was isolated from cells using InstaPure reagent (Eurogentec, Seraing, Belgium) according to the manufacturer's instructions. Reverse transcription was performed with M-MuLV reverse transcriptase (Finnzymes, Espoo, Finland) using random heptameric primers. The mixture of 3 μg of total RNA and random primers (400 ng/μl) was heated for 10 min at 70
• C, The amplification of the samples was carried out in a final volume of 20 μl on StepOne TM Real-Time PCR System (Applied Biosystems), using the following program: initial denaturation at 95
• C for 10 min followed by 40 cycles of: denaturation at 95
• C for 15 s and annealing at 60
• C for 1 min. All PCR reactions were performed in triplicate and repeated three times.
ChIP assay
HeLa cells were plated into 500 cm 2 plates at ∼ 90 % density, left to attach overnight and incubated in hypoxia in the absence or presence of 10 nM TCDD for 2 h. The cells were fixed in 1 % formaldehyde in PBS for 10 min at room temperature (21
• C). Chromatin isolation, shearing to the size of ∼ 600-800 bp and immunoprecipitation with rabbit polyclonal antibodies against ARNT [29] were performed as described in [34] . Anti-human IgG antibodies (rabbit polyclonal, Abcam) were used as a negative control and for chromatin preclearing.
Purified DNA was subjected to 35 cycles of PCR with primers flanking the putative HRE (hCA9-HRE-S: 5 -TCCTAGCTT-TGGTATGGGGGAGAG-3 and hCA9-HRE-A: 5 -AGTGACA-GCAGCAGTTGCACAGT-3 ; 277 bp product) within the CA9 promoter. Primers flanking the XRE of the CYP1A1 promoter (hCYP1A1-XRE-S: 5 -CACCCTTCGACAGTTCCTCTCCCT-3 and hCYP1A1-XRE-A: 5 -CTCCCGGGGTGGCTAGTGCTT-TGA-3 ; 391 bp product) were used as a positive control.
Statistical analysis
Results were analysed by two-tailed unpaired t test (Student's t test), and P < 0.05 was considered significant.
RESULTS AND DISCUSSION
TCDD inhibits hypoxia-induced CA IX expression
Our initial aim was to determine whether TCDD treatment influences expression of CA IX. For this purpose, HeLa cells grown in sparse culture were treated under both normoxic and hypoxic conditions with TCDD and DMSO as a control, and CA9 mRNA expression was analysed using real-time PCR ( Figure 1A ). As expected, the highest level of CA9 expression was observed in control HeLa cells exposed to hypoxia for 24 h, whereas TCDD treatment significantly decreased CA9 mRNA levels under hypoxic conditions. Owing to the sparse culture conditions of the treated cells, the expression of CA9 in normoxia was very low and statistically insignificant. Subsequently, results obtained by realtime PCR were confirmed by Western blotting of corresponding protein level ( Figure 1B) . Treatment of HeLa cells with both concentrations of TCDD under hypoxic conditions resulted in a decrease in CA IX protein.
Expression of CYP1A1 was also determined by real-time PCR as a control for induction of the dioxin-responsive pathway ( Figure 1A ). In accordance with previous observations [30] , hypoxia decreased expression of TCDD-induced CYP1A1, suggesting a reciprocal influence between the hypoxia and dioxin signalling pathways in the cell culture model used in our experiments.
These experiments suggested that TCDD treatment inhibited CA9 expression at the transcriptional level. Therefore, in the next step, we decided to analyse this mode of inhibition utilizing CA9 promoter constructs in reporter gene experiments.
HIF-1 binding site within CA9 promoter is critical for dioxin mediated inhibition
Previous studies have determined the region − 174 nt upstream from the transcription start site as the basal CA9 promoter.
Moreover, the − 50 nt proximal region of the CA9 promoter containing the SP1-binding site and HRE was found to be crucial for responses to cell density and hypoxia [11, 35] .
In order to determine the region critical for CA9 promoter inhibition caused by the dioxin-induced AhR pathway, we used HeLa cells transiently transfected with the − 174/+ 37 luciferase reporter construct [16] and treated with TCDD for 24 h in normoxia or hypoxia. Activation of AhR by TCDD treatment led to reduced activity of the − 174/+ 37 luciferase reporter construct. Simultaneously, in order to examine direct effects of AhR on CA9 transcription, HeLa cells were co-transfected with 1 μg of CAAhR, which is known to activate transcription in a ligandindependent manner. This construct is not subject to repression by the ligand-binding domain in the absence of dioxin and may, in fact, under certain conditions show a more potent effect as transactivator than the ligand-occupied wild-type receptor [32] . As shown in Figure 2 (A), both TCDD treatment and CAAhR co-transfection significantly reduced promoter activities, with CAAhR being a more potent inhibitor.
To confirm functionality of the CAAhR in our assay, CAAhRexpressing HeLa cells were also co-transfected with the XREcontaining reporter plasmid pTX.DIR ( Figure 2B ) [30] . As expected, CAAhR dramatically elevated pTX.DIR reporter activity under normoxia and in the absence of AhR ligand. On the other hand, this activity was markedly diminished under hypoxic conditions to approx. one half of the CAAhR-induced value, thus providing additional evidence of a reciprocal impact between the hypoxia and dioxin pathways under these assay conditions.
CAAhR was also transiently expressed in HeLa cells in the presence of the minimal CA9 promoter (− 50/+ 37) (Figure 2A) . In a manner similar to that described above, overexpression of CAAhR resulted in significant inhibition of the activity of the minimal reporter construct. The minimal CA9 promoter only contains SP1 and HIF-1 binding sites, therefore it seems plausible that the TCDD-and CAAhR-mediated CA9 repression may affect these transcription factors.
In the case of the CA9 promoter, both HIF-1α and SP1 are indispensable in responsiveness to hypoxic-and cell densitydependent induction. To determine the significance of these factors in CA9 repression, HeLa cells were co-transfected with equal amounts of CAAhR and expression vectors of either HIF-1α, SP1 or co-factors, and with the basal CA9 reporter plasmid. Co-transfection with the empty vector did not have any effect on CAAhR-mediated inhibition of reporter gene activity. In contrast, the expression of HIF-1α completely abrogated CAAhRmediated inhibition of promoter activity. On the other hand, introduction of SP1 did not have this effect of counteracting CAAhR-mediated repression of CA9 expression ( Figure 2C) . Moreover, transient co-expression of p300 and CAAhR did not have any effect on CAAhR-mediated inhibition of the hypoxic induction of the CA9 promoter ( Figure 2C) . It is well known that the co-activator CBP/p300 functionally and physically interacts with HIF-1α/ARNT as well as with the AhR/ARNT complex and supports their functional activity in a conditionally-regulated manner [36] .
We have to keep in mind that AhR could disrupt a HIF-1α-SP1 complex and by this mechanism reduce CA9 promoter activity. In this situation HIF-1α, due to its lower abundance compared with SP1, could be a limiting factor.
TCCD-mediated inhibition of CA9 expression is strictly dependent on the presence of ARNT
In order to form a transcriptionally functional complex, both HIF-1α and AhR must dimerize with their common partner ARNT. It has been reported that these pathways can mutually interfere with one another by competition for recruitment of ARNT [25, 27, 30, 37] . To elucidate whether AhR-mediated inhibition of CA9 expression is dependent on ARNT, we performed transfection experiments using both wild-type and ARNT-deficient mouse hepatoma cell lines. As shown in Figure 3 (A), hypoxic induction of CA9 reporter activity was observed in wild-type Hepa-1c1c7 cells, but was not detected in Hepa-1c4 cells expressing a functionally deficient form of ARNT [38] . In the presence of TCDD, hypoxic induction of CA9 promoter activity was decreased in a dioxin dose-dependent manner ( Figure 3B ). Transient expression of CAAhR did not have any effect on the CA9 promoter activity in Hepa-1c4 cells either under normoxic or hypoxic conditions. On the other hand, the inhibitory effect of CAAhR was restored following co-expression of wild-type ARNT ( Figure 3C ). Most notably, this inhibition became significant only after hypoxic treatment of Hepa-1c4 cells. The results obtained from the present experiments demonstrate that AhR/CAAhRmediated inhibition of CA9 expression is critically dependent on a functional ARNT.
AhR activation directly affects binding of ARNT to the CA9 promoter
The fact that both HIF-1α and AhR require dimerization with ARNT to form functional transcription complexes prompted us to consider the possible rivalry between both transcription factors for ARNT binding. To get more direct proof about the possibility of cross-talk between hypoxia and dioxin pathways in the regulation of CA9 expression, we performed ChIP assays. In order to activate CA9 expression, HeLa cells were grown in hypoxia and subsequently treated with TCDD to ensure the activation of AhR. DMSO-treated cells were used as a negative control. The cells were then fixed with formaldehyde and sheared chromatin was immunoprecipitated with either ARNT-specific or IgG control antibodies. Finally, ARNT-specific immunoprecipitation was investigated by PCR reaction. As shown in Figure 4 , PCR performed with the primers flanking HRE within the CA9 promoter clearly demonstrates a weaker signal detected after ARNT-specific DNA precipititation in the TCDD-treated cells when compared with control cells. The proper functionality and activation of AhR in our assay conditions was confirmed by PCR performed on the same precipitated DNA utilizing primers flanking XRE within the CYP1A1 promoter (Figure 4 ). This result directly implies possible inhibition of CA9 expression by decreasing the number of ARNT molecules accessible for binding to the HRE within the CA9 promoter.
It has already been postulated by several research groups that activation of one pathway would inhibit the other due to competition for ARNT or other limiting cellular factors. In agreement with the present results obtained from ChIP, Chan et al. [25] also observed in gel mobility-shift experiments that AhR inhibited formation of the HIF-1α/ARNT complex with HREs, and, conversely, that HIF-1α inhibited formation of the AhR/ARNT complex with an XRE motif. In an earlier report, it was demonstrated in vitro that HIF-1α exhibits a very high affinity for ARNT, resulting in competition with the activated AhR for the recruitment of ARNT [30] . A similar observation was made following overexpression of HIF-1α, resulting in an apparent inhibition of the DNA-binding activity of dioxinactivated AhR [30] . In those experiments, however, activation of both hypoxia-and dioxin-signalling pathways was not mutually exclusive because activation of the AhR pathway did not result in inhibition of hypoxia-dependent expression of target genes. On the other hand, there is a conflicting report stating that the DNA-binding activity of AhR/ARNT heterodimers was only slightly reduced under hypoxic conditions [26] . Regardless of the identification of cross-talk between hypoxia and dioxin pathways, even Pollenz and colleagues failed to detect competition between HIF-1α and AhR for ARNT binding [39] .
Taken together, these seemingly conflicting reports would argue that the interplay between both pathways would obviously be dependent on the architecture of the target promoter/enhancer and the battery of cognate transcription factors and co-factors in close connection with the extent of chromatin remodelling but, importantly, competition for ARNT might be a valid scenario for negative regulation. In particular, this model is supported by the limiting ARNT concentrations observed in most cell types.
Recently it has been reported that the environmentally abundant polycyclic aromatic hydrocarbon benzo[a]pyrene downregulates VEGF (vascular endothelial growth factor) expression through disruption of HIF-1α and Hsp90 association, which promotes ubiquitination and subsequent degradation of HIF-1α by the proteasome [40] . This is most probably not the mechanism underlying CAAhR-mediated downregulation of CA9 expression, because, in contrast with the wild-type dioxin receptor, CAAhR lacks the minimal ligand-binding domain (PASB domain) and is therefore active in both a ligand-and Hsp90-independent manner [32] .
A large scale microarray analysis has previously been employed to determine the extent of cross-talk between the hypoxia-and dioxin-signalling pathways. Interestingly, CA IX was identified among 33 unique transcripts, the expression of which was affected by both pathways [41] . Computational analysis of these genes identified some common DNA motifs present in their regulatory regions. This observation might help to distinguish between results obtained from different experiments done on different cell culture models and with distinct target genes and their regulatory regions. Nevertheless, these results should be interpreted with caution as Lee et al. [41] used cobalt chloride as a mimic of hypoxic conditions.
In the present study we have demonstrated that the activated AhR can impair hypoxic induction of both CA IX mRNA and protein expression. We have thus observed cross-talk between hypoxia and AhR pathways in the regulation of CA9 expression. This mode of regulation seems to occur primarily at the transcriptional level. We have further provided evidence for competition between HIF-1α and AhR for limited intracellular levels of ARNT. This mode of competition for recruitment of ARNT may play a role in CA IX regulation in tumours that are exposed to xenobiotics.
From the pathophysiological point of view it is quite conceivable that exposure to dioxin could have a negative influence on normal cells and tissues that rely on protective mechanisms activated by HIF-regulated pathways. However, the situation might be more complicated in tumours due to a high plasticity of malignant cells which could react to acute exposure to dioxin or other xenobiotics by a transiently reduced hypoxic response. On the other hand, chronic exposure might induce either a switch to alternative pathways, or to selection of those tumour cells which are able to return back to the hypoxic phenotype that provides a significant survival advantage in hostile tumour microenvironment. These issues were not addressed in any of the studies published so far and remain to be resolved in different experimental settings in work that is currently underway.
In conclusion, our observations support the model that the existence of limiting concentrations of bHLH/PAS proteins is involved in the cross-talk among members of this protein family. The expression of CA IX is strongly induced by hypoxia and its distribution in tumour tissues significantly correlates with poor prognosis of many tumour types. Our results extend data about factors and signalling pathways involved in the regulation of CA IX expression. 
